Read the latest insights we've been sharing on LinkedIn

January 23, 2025

IRA…. round 2

by Real Endpoints

As expected, the U.S. Department of Health and Human Services announced the second round of drugs that will be subject to “negotiation” under the Inflation Reduction Act. It’s the last major healthcare move from the Biden Administration and a chance to keep the momentum going on its signature leglislation. Here is what we know – and what we don’t.

LinkedIn >

January 22, 2025

Welcome to the Real Endpoints team, Shana!

by Real Endpoints

We are so excited to announce that we have hired Shana Trexler as a Senior Account Executive to advance sales of RE Assist. A Fierce Healthcare Innovation winner in 2024, RE Assist is an innovative tool that supports people living with disease find financial support for their treatment costs.

LinkedIn >

January 16, 2025

Some off the cuff thoughts from Real Endpoints CEO Jeff Berkowitz as this year’s JPM Healthcare Conference comes to a close.

by Real Endpoints

LinkedIn >

December 12, 2024

Real Endpoints co-hosts inaugural Cell Therapy Commercialization Leadership Forum

by Jeff Berkowitz

Real Endpoints' was privileged to co-host the inaugural Cell Therapy Commercialization Leadership Forum along with Adjuvant Partners and Leavitt Partners with support from McKesson, FFF Enterprises and CIRM.

LinkedIn >

December 12, 2024

RE Assist named Fierce Healthcare Innovation Award winner in the Financial/Operational Solutions category.

by Real Endpoints

We’re excited and honored that Fierce Healthcare named Real Endpoints financial assistance tool RE Assist as the Fierce Healthcare Innovation Award winner in the Financial/Operational Solutions category.

LinkedIn >

October 29, 2024

Real Endpoints – Fierce Innovation Awards Finalist 2024

by Real Endpoints

We are so excited to announce that we’ve been shortlisted for the Fierce Innovation Awards: Healthcare Edition 2024.

read full article >